Researcher profile

Giulia Pedrielli

Giulia Pedrielli contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2023arXiv

Parameter Optimization with Conscious Allocation (POCA)

The performance of modern machine learning algorithms depends upon the selection of a set of hyperparameters. Common examples of hyperparameters are learning rate and the number of layers in a dense neural network. Auto-ML is a branch of optimization that has produced important contributions in this area. Within Auto-ML, hyperband-based approaches, which eliminate poorly-performing configurations after evaluating them at low budgets, are among the most effective. However, the performance of these algorithms strongly depends on how effectively they allocate the computational budget to various hyperparameter configurations. We present the new Parameter Optimization with Conscious Allocation (POCA), a hyperband-based algorithm that adaptively allocates the inputted budget to the hyperparameter configurations it generates following a Bayesian sampling scheme. We compare POCA to its nearest competitor at optimizing the hyperparameters of an artificial toy function and a deep neural network and find that POCA finds strong configurations faster in both settings.

preprint2022arXiv

A model aggregation approach for high-dimensional large-scale optimization

Bayesian optimization (BO) has been widely used in machine learning and simulation optimization. With the increase in computational resources and storage capacities in these fields, high-dimensional and large-scale problems are becoming increasingly common. In this study, we propose a model aggregation method in the Bayesian optimization (MamBO) algorithm for efficiently solving high-dimensional large-scale optimization problems. MamBO uses a combination of subsampling and subspace embeddings to collectively address high dimensionality and large-scale issues; in addition, a model aggregation method is employed to address the surrogate model uncertainty issue that arises when embedding is applied. This surrogate model uncertainty issue is largely ignored in the embedding literature and practice, and it is exacerbated when the problem is high-dimensional and data are limited. Our proposed model aggregation method reduces these lower-dimensional surrogate model risks and improves the robustness of the BO algorithm. We derive an asymptotic bound for the proposed aggregated surrogate model and prove the convergence of MamBO. Benchmark numerical experiments indicate that our algorithm achieves superior or comparable performance to other commonly used high-dimensional BO algorithms. Moreover, we apply MamBO to a cascade classifier of a machine learning algorithm for face detection, and the results reveal that MamBO finds settings that achieve higher classification accuracy than the benchmark settings and is computationally faster than other high-dimensional BO algorithms.

preprint2022arXiv

From Discovery to Production: Challenges and Novel Methodologies for Next Generation Biomanufacturing

The increasingly pressing demand of novel drugs (e.g., gene therapies for personalized cancer care, ever evolving vaccines) with unprecedented levels of personalization, has put a remarkable pressure on the traditionally long time required by the pharma R&D and manufacturing to go from design to production of new products. The revolution has already brought important changes in the technologies used within the industry. In fact, practitioners are increasingly moving away from the classical paradigm of large-scale batch production to continuous biomanufacturing with flexible and modular design, which is further supported by the recent technology advance in single-use equipment. In contrast to long design processes, low product variability (one-fits-all), and highly rigid systems, modern pharma players are answering the question: can we bring design and process control up to the speed that novel production technologies give us to quickly set up a flexible production run? In this tutorial, we present key challenges and potential solutions from the world of operations research that can support answering such question. We first present technical challenges and novel methods for the design of next generation drugs, followed by the process modeling and control approaches to successfully and efficiently manufacture them.